| ORIGINAL ARTICLE |
|
| Year : 2021 | Volume
: 11
| Issue : 4 | Page : 267-273 |
|
|
Formulation and Standardization of Siddha Pediatric Tablet dosage: Bala Sanjeevi Mathirai
Shree Devi Munusamy Sampangi Ramulu1, Parameswaran Sathiyarajeswaran1, Kirubakaran Narayanan1, Soman Vinayak1, Kiruthiga Ganesan2, Kadarkarai Kanakavalli2
1 Siddha Central Research Institute (SCRI), Central Council for Research in Siddha (CCRS), Ministry of AYUSH (Govt. of ), Arumbakkam, Chennai, Tamil Nadu, India
2 Central Council for Research in Siddha (CCRS), Ministry of AYUSH (Govt. of ), Arumbakkam, Chennai, Tamil Nadu, India
Correspondence Address:
Shree Devi Munusamy Sampangi Ramulu
Siddha Central Research Institute (SCRI), Central Council for Research in Siddha (CCRS), Ministry of AYUSH (Govt. of India), Arumbakkam, Chennai, Tamilnadu-600106
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijnpnd.ijnpnd_25_21
|
|
|
Herbal remedies have grown at an exponential rate since ancient times. Traditional medicines require newer standardization, manufacturing, quality control, and scientifically rigorous research to meet standardization. Bala Sanjeevi Mathirai (BSM) is a Siddha pediatric tablet formulation used for the treatment of cough, fever, vomiting, biliousness, and diarrhoea occurring in children due to dyspepsia. This work was purposed to formulate and standardize BSM as per the guidelines set forth by the regulatory authorities (PLIM). Three validation batches of the formulation were prepared. Tablets were standardized by different physiochemical parameters and evaluated by various studies such as precompression and post compression parameters. All parameters were passed with reference to the standard limits. The set parameters were sufficient to evaluate the tablet and further this could be used as reference standards for the quality control/quality assurance laboratory of the pharmaceutical house.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
